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Central necrosis is a common feature in invasive breast cancer and
is associated with poor outcome and tumour aggression. For
example, findings from the National Surgical Adjuvant Breast
Project showed that, after 10 years’ follow-up, the presence of
moderate to marked central tumour necrosis was associated with
reduced relapse-free survival and increased mortality in both
node-positive and node-negative patients (Fisher et al, 1993) with
invasive breast carcinoma. The term necrosis may be defined as
the morphological changes following cell death, and may be coag-
ulative where the tissue is solid and the original structures are
largely preserved. In this case, the autolytic enzymes are inactive
and the cells within an area of coagulative necrosis retain their
shape but are highly eosinophilic ‘ghosts’ of their previous form.
After a period of time, this pattern is replaced by liquefaction
necrosis, in which the cellular structures are broken down by
proteolytic enzymes released from ruptured lysosomes and similar
enzymes released by infiltrating inflammatory cells (Woolf, 1986).
It is thought that tumour necrosis is caused by chronic ischaemia
(i.e. hypoxia, low pH, low glucose, high lactate) within tumours,
caused by vascular collapse, blood shunting to other sites and/or
rapid tumour cell growth overtaking the rate of neovascularization
in a given area.
The involvement of hypoxia in tumour progression, and espe-
cially tumour angiogenesis, has become a prominent area of
research in recent times. Moreover, the degree of tumour hypoxia
has been inversely correlated with response to radio- and various
chemotherapies and overall survival (reviewed by Dachs et al,
1996). Angiogenesis is a multistep process involving complex
cellular interactions between endothelial cells and malignant
epithelial cells, stromal cells and the tumour matrix. The process
of angiogenesis is distinct from that of vasculogenesis, in that it is
the process of vessel formation derived from existing vasculature.
A number of studies have shown that it is an essential requirement
for tumour growth and metastasis (Blood and Zetter, 1990), and
that hypoxia may be a primary driving force behind angiogenesis
in malignant tumours.
Hypoxia up-regulates the expression of a number of angiogenic
growth factors, and the hypoxia-inducible transcription factor,
hif-1a, has been found to be involved in the up-regulation of a
number of hypoxia-adaptive mechanisms within tumour cells.
These include up-regulation of glycolytic enzymes such as lactate
dehydrogenase and phosphoglycerol kinase (which help tumour
cells to switch to anaerobic glycolysis in hypoxia) (Semenza et al,
1994), as well as the angiogenic growth factor vascular endothelial
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Summary Necrosis is a common feature of invasive carcinoma of the breast and is caused by chronic ischaemia leading to infarction.
Although necrosis was previously assumed to be due to a generally poor blood supply in the tumour, in this study we show that it is present
in tumours with focal areas of high vascular density situated away from the actual sites of necrosis. This may account, in part, for the previous
observation that necrosis is linked to poor prognosis in this disease. Highly angiogenic tumours often display blood vessel shunting from one
tumour area to another, which further exacerbates ischaemia and the formation of tumour necrosis. We have recently demonstrated that high
focal microphage infiltration into breast tumours is significantly associated with increased tumour angiogenesis and poor prognosis and that
the macrophages accumulate in poorly vascularized, hypoxic areas within breast tumours. In order to investigate the interactions of
macrophages with chronic ischaemia (as reflected by the presence of necrosis) and angiogenesis in breast tumours, we quantified the levels
of these three biological parameters in a series of 109 consecutive invasive breast carcinomas. We found that the degree of tumour necrosis
was correlated with both microphage infiltration (Mann–Whitney U,  P-value = 0.0009; chi-square, P-value = 0.01) and angiogenesis
(Mann–Whitney  UP -value = 0.0008, chi square P-value = 0.03). It was also observed that necrosis was a feature of tumours possessing an
aggressive phenotype, i.e. high tumour grade (chi-square, P-value < 0.001), larger size (Mann–Whitney U,  P-value = 0.003) and low
oestrogen receptor status (Mann–Whitney U, P-value = 0.008; chi-square, P-value < 0.008). We suggest, therefore, that aggressive tumours
rapidly outgrow their vascular supply in certain areas, leading to areas of prolonged hypoxia within the tumour and, subsequently, to necrosis.
This, in turn, may attract macrophages into the tumour, which then contribute to the angiogenic process, giving rise to an association between
high levels of angiogenesis and extensive necrosis.
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regulate angiogenesis indirectly via its effect on tumour-associated
macrophages (TAMs). We have recently demonstrated an associa-
tion between focal TAM infiltration and reduced relapse-free and
overall survival in breast carcinomas. We have also shown that
high levels of macrophages in focal areas (MØI) are associated
with increased vascular density and that macrophage clusters are
found in avascular areas of breast tumours (Leek et al, 1997). As
macrophages have been shown to release such proangiogenic
cytokines as  vascular endothelial growth factor (Harney et al,
1998) tumour recrosis factor a (TNF-a) in response to hypoxia
(Scannell et al, 1993), it is possible that, once macrophages reach
hypoxic/ischaemic tumour sites, they may promote tumour growth
and metastasis by releasing these factors to stimulate angiogen-
esis. Therefore, the purpose of this study was to assess quantita-
tively the degree of central necrosis in a consecutive series of
invasive breast carcinomas and to examine its relationship to both
focal microphage infiltration and angiogenesis, as measured by
quantitative CD68 and CD31 immunohistochemistry of vessel and
macrophage ‘hotspots’ respectively (Fox et al, 1995; Leek et al,
1996, 1997).
MATERIALS AND METHODS
Tumours and patients
A consecutive series of 109 surgically resected invasive breast
carcinomas were retrieved from the archives of the John Radcliffe
Hospital, Oxford, UK. Surgery had been performed between 1989
and 1992, all had undergone axillary node sampling, and the pres-
ence of nodal metastasis was confirmed histologically. The modi-
fied Bloom and Richardson method was used to grade all invasive
carcinomas of ductal type (Elston, 1987), and all patients were
followed up every 3 months for the first 18 months and every 6
months thereafter. The characteristics of this series of tumours are
detailed in Table 1. All patients received either simple mastectomy
or lumpectomy and radiotherapy; adjutant radiotherapy was admin-
istered to the ipsilateral axilla if histological evidence of nodal
metastasis was found. Patients with confirmed recurrent disease
were treated by endocrine manipulation for soft tissue or skeletal
disease or by chemotherapy for visceral disease or failed endocrine
therapy. Patients with isolated soft-tissue relapse received radio-
therapy. Details of adjuvant treatment consisting of tamoxifen for 5
years and cyclophosphamide, methotrexate and 5-fluorouracil
(CMF) intravenously for six courses are shown in Table 1.
Assessment of tumour necrosis
Necrosis was subjectively graded into three categories using
routinely processed haematoxylin and eosin-stained histological
sections. 0 = no necrosis, 1 = focal areas of necrosis (<25% of
tumour), 2 = widespread areas of necrosis (25–75% of tumour) and
3 = virtually all necrosis (75–100% of tumour). For cut-off point
analyses the presence of any necrosis was considered positive.
Tumour hormone receptor status
Oestrogen receptor (ER) analysis was performed using an
enzyme-linked immunosorbent assay (ELISA) technique (Abbott
Laboratories, USA). Tumours with cytoplasmic oestrogen levels
higher than 5 fmol mg–1 protein were considered positive (EORTC
Breast Cancer Co-operative Group, 1980). Epidermal growth
factor receptor (EGFR) was determined using ligand binding of
[125I]EGF to tumour membranes. Tumours with an EGFR level of
greater than 20 fmol mg–1 protein were considered positive
(Nicholson et al, 1988).
Vascular grade and macrophage index
Chalkley vascular count (CVC) and focal macrophage infiltration
(MØI) were quantitatively determined using Chalkley point array
counting methodologies described by us and others previously
(Fox et al, 1995; Leek et al, 1996). Vessels are stained immuno-
histochemically using an antibody against CD31, and
macrophages are stained with anti-CD68. Using this system, CVC
and MØI are determined microscopically by enumerating the
numbers of either vessels or macrophages in the three areas of the
section at high power (´25 objective) which show the most dense
staining, the so called ‘hotspot’ areas. For cut-off point analysis
the medians were used to categorize tumours into high and low
groups (high CVC ³7, high MØI ³12).
Statistical analysis
Chi-square and Fisher’s exact tests were used to investigate relation-
ships between categorical tumour variables, and Mann–Whitney
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Table 1 Clinical and pathological features of tumours and patients
Patient characteristics Number
Age (median, range) years 55 (28–83)
<50 42
³50 67
Surgical treatment
Lumpectomy + RT 95
Mastectomy 14
Adjuvant treatment
Chemotherapy 29
Tamoxifen 50
Lymph node status
Negative/positive 72/37
Tumour size (median, range) cm 2.3 (1–7)
<2 36
³25 7
Histology
Ductal 88
Lobular 8
Others 13
Grade
I9
II 43
III 36
ERa (median, range) 9.7 (0–695)
<10 56
³10 53
EGFRa (median, range) 18.2 (0–710)
<20 58
³20 49
Survival follow-up (median, range) months 63 (1.7–93)
Deaths, recurrences 31, 37
afmol mg–1 protein.non-parametric tests were utilized to compare categorical with
continuous tumour variables. These analyses were performed using
Statview 4.5 statistical analysis software (Abacus concepts,
Berkeley, CA, USA). Survival analysis was performed using the
log-rank test to evaluate differences between life tables. Survival
analyses were accomplished using Stata release 3.1 software (Stata
Corp., College Station, TX, USA).
RESULTS
Distribution of necrosis grading
In this series of 109 breast cancers, 29 (26.6%) cases were necrosis
grade 1, 16 (14.7%) cases necrosis grade 2 and only one case was
grade 3 (0.9%). This gave a total of 46 cases with necrosis present
(42.2%) compared with 63 with no necrosis (57.8%). For this
reason it was decided, for the purposes of statistical analysis, to
split the data into two groups of those with and those without
necrosis.
Relationship of necrosis to clinicopathological tumour
variables
Tumour necrosis was compared with tumour variables known to
relate to outcome, including node status, size of tumour at excision,
patient age, histological type, grade, ER expression and EGFR
expression. A number of significant associations were observed,
including positive associations between the presence of necrosis
with tumour size (Mann–Whitney U, P = 0.003) and increasing age
of patient (Mann–Whitney U, P = 0.02), when these data were
examined as continuous variables. An association was also seen
between increasing necrosis grade and high tumour grade (chi
square,  P = 0.0001) (Table 2). When examining ER and EGFR, an
inverse association was observed between ER expression and
necrosis (Mann–Whitney U, P = 0.008; chi square, P = 0.007)
(Table 2). Conversely, a positive association was noted between
EGFR and the degree of necrosis when using the lower necrosis
cut-off point (Mann–Whitney U, P = 0.047). No associations were
seen between necrosis and node status or histological type.
Relationship of necrosis to vascular count and focal
macrophage infiltration
When tumour necrosis was compared with vascular count and
macrophage index, significant associations were observed with
both variables (see Table 3 for summary). An association was
noted between higher vascular density and increasing necrosis
(Mann–Whitney  U, P = 0.008; chi-square, P = 0.03). Also, signif-
icant positive associations were observed between increasing
macrophage index and the degree of necrosis (Mann–Whitney U,
P = 0.0009; chi-square, P = 0.01), with high numbers of TAMs
often seen to lie within the palisading region around areas of
necrosis.
Necrosis and prognosis
No effect was observed on either relapse-free (RFS) or overall
survival (OS) by the presence of necrosis [log-rank (Mantel–Cox):
RFS, P = 0.27; OS, P = 0.87] or high levels of necrosis [log-rank
(Mantel–Cox); RFS, P = 0.56; OS, P = 0.82].
DISCUSSION
Tumour necrosis is generally thought to result from rapidly prolif-
erating tumour cells outpacing their blood supply in certain areas.
This causes areas within the tumour which are poorly vascularized
to become ischaemic. If this condition is sustained in these
regions, the result is the onset of necrosis. In this study of breast
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Table 2 Summary of chi-square tests showing associations between necrosis and other tumour variables
Observed frequencies
Grade ERa
1 2 3 ER negative ER positive
Necrosis 0 14 25 31 15
No necrosis 9 29 11 25 38
Chi-square 18.7 8.2
Chi-square P-value <0.001 <0.008
Table 3 Summary of chi-square tests showing associations between necrosis and angiogenesis and macrophage infiltration
Observed frequencies
Vascular density Macrophage index
High CVC Low CVC High MØI Low MØI
Necrosis 17 29 37 9
No necrosis 10 51 34 27
Chi-square 5.9 7.2
Chi-square P-value 0.03 0.01carcinomas, we found the presence of tumour necrosis to be
related to higher levels of angiogenesis, as measured by increased
vascular density in focal areas. Highly necrotic tumours also
contained higher levels of focal macrophage infiltration. These
results accord well with other previous, albeit only semiquantita-
tive, reports in which simply the presence of necrosis in breast
carcinomas was correlated with (1) decreased survival and total
vessel counts in highly vascularized tumour areas (Kato et al,
1997) and (2) diffuse tumour infiltration by macrophages (Lee et
al, 1997). However, neither of these studies attempted to quantify
the actual amount of necrosis present. Furthermore, Lee et al
(1997) only loosely assessed the general level of TAM infiltration
per tumour. In the present study, we have used previously
published methods to quantify the degree of necrosis as well as the
highest density of vessels and macrophages in defined areas of the
tumour where ‘hotspots’ of these cells occur. These parameters
were chosen, rather than an assessment of the total number of
vessels or macrophages across the tumour as a whole, as we have
previously shown that these correlate with such important indices
of tumour aggressivity such as lymph node status and/or prognosis
(Fox et al, 1995; Leek et al, 1996, 1997).
The finding that higher levels of necrosis were present in more
angiogenic tumours may appear at first to be counterintuitive.
However, a contributing factor to tumour progression is angio-
genesis, and increased angiogenesis in certain areas leads to rapid
growth of the tumour cells at those sites. This will lead to the
development of focal areas of ischaemia within such fast-growing
tumours as neoplastic cell proliferation follows and then outstrips
angiogenic induction. This assertion is also supported by the fact
that necrosis is associated with larger tumours and those of high
grade as well as increasing EGFR, and is inversely associated with
ER expression, indicating that necrosis is a feature of tumours
possessing an aggressive phenotype. It is interesting to note that
the levels of tumour necrosis appear to drop with increasing age of
the patient, indicating once again that necrosis may be correlated
with tumour aggressivity as breast tumours in younger patients are
often of a more aggressive nature.
In addition, high levels of angiogenesis may not actually corre-
spond to improved blood flow within tumours as the new blood
vessels are incomplete and often lack structural integrity (Blood
and Zetter, 1990). They may collapse and block flow or they may
not be capable of containing arterial pressure within their struc-
ture, leading to localized haemorrhage. Anastomosis of new
vessels may also lead to shunting of the blood flow, resulting in
poor flow in vessels efferent to shunts (Helmlinger et al, 1997).
The findings of this study suggest that tumour ischaemia may be
an important factor in the stimulus of tumour growth. It is well
known that a number of angiogenic factors are up-regulated by
hypoxia (Dachs et al, 1996), including VEGF (Forsythe et al,
1996), and that hypoxic tumour cells may, therefore, stimulate
angiogenesis directly via their release of such factors. Indeed,
Plate and Warnke (1997) and others have shown the up-regulation
of angiogenic factor expression around areas of necrosis in breast
carcinomas.
Our finding that increased necrosis was associated with higher
levels of focal macrophage infiltration, and that a high number of
macrophages cluster around necrotic areas, matches a similar
report by Negus et al (1997) in malignant ovarian tumours. We
have previously demonstrated that in breast cancer increased MØI
is associated with reduced overall and relapse-free survival, and is
also associated with increased angiogenesis. We have also shown
that TAM hotspots are located in avascular areas of tumours,
suggesting that they preferentially migrate towards areas of rela-
tive hypoxia (Leek et al, 1997). Indeed, when macrophages infil-
trate into multicell tumour spheroids in vitro, they accumulate
rapidly in and around the hypoxic and necrotic central area of
these three-dimensional cultures of tumour cells (Lewis, 1996).
We have, therefore, suggested that the TAM population of tumours
may be important contributors to the stimulation of tumour angio-
genesis, as they are also capable of producing a large repertoire of
angiogenic factors, including angiogenic cytokines such as VEGF
and TNF-a, and proteolytic enzymes (Lewis et al, 1995; Leek et
al, 1997, 1998). Indeed, it is our intention to examine expression
of such factors by macrophages, both in human tumours and in
experimental models. It would seem that macrophages are
attracted to necrotic tumours, perhaps by chemotactic factors
released by dead/dying or hypoxic tumour cells, such as VEGF,
which is chemotactic for macrophages (Clauss et al, 1990).
The results from this study show that necrosis, resulting from
chronic ischaemia, is associated with high rather than low angio-
genesis. As macrophage infiltration is also elevated in these more
necrotic, highly angiogenic tumours, we suggest that macrophages
may play a key role in the aggressive tumour phenotype, in part by
promoting tumour angiogenesis.
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